Reply to Trudeau, M.; Fraser, B. The CADTH pCODR Expert Review Committee Process Explained. Comment on "Rayson et al. Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain. Curr. Oncol. 2022, 29, 9891-9895"

Recurrent Pubic Osteomyelitis and Urosymphyseal Fistula in a Prostate Cancer Survivor: A Multidisciplinary Management Challenge.

Journal of community hospital internal medicine perspectives·2026

Primary Nodal Poroid Hidradenocarcinoma With YAP1::NUTM1 Fusion: Report of a Rare Case.

Journal of cutaneous pathology·2026

Association of cancer antigen 15-3 with distant recurrence in immunohistochemically defined breast cancer subtypes in Canadian Cancer Trials Group MA.32.

JNCI cancer spectrum·2026

Pathological assessment of tumour beds in breast excisions post-neoadjuvant therapy: a retrospective cohort study.

Histopathology·2026

Early tumour size changes from neoadjuvant chemotherapy as a predictor of pathologic response in breast cancer.

PloS one·2026

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with Triple Negative Breast Cancer in Both the Early and Metastatic Setting 2025.

Current oncology (Toronto, Ont.)·2026

Correction: Gould et al. Emergency Use of Targeted Osmotic Lysis for the Treatment of a Patient with Aggressive Late-Stage Squamous Cell Carcinoma of the Cervix. Curr. Oncol. 2021, 28, 2115-2122.

Current oncology (Toronto, Ont.)·2026

Trends in Volume, Timeliness, and Reporting Quality of Oncology Systematic and Scoping Reviews: A 25-Year Analysis.

Current oncology (Toronto, Ont.)·2026

Sentinel Lymph Node Mapping Without Intraoperative Frozen Section in Preoperative Endometrial Intraepithelial Neoplasia/Atypical Endometrial Hyperplasia: Feasibility, Diagnostic Yield, and the Estimated Consequence of Frozen-Section Triage.

Current oncology (Toronto, Ont.)·2026

Pre-Spondylectomy Radiofrequency Ablation for Spinal Chordoma: An Illustrative Case and Systematic Review of Clinical Applications and Outcomes.

Current oncology (Toronto, Ont.)·2026

Prediction of Immune Checkpoint Inhibitor-Induced Liver Injury in Patients with Gastrointestinal Cancer: Machine Learning Modeling for Time-Stratified Risk Assessment.

Current oncology (Toronto, Ont.)·2026

Multidimensional Recovery Trajectories Throughout Breast Cancer Treatment and Survivorship: A Prospective Longitudinal Study.

Current oncology (Toronto, Ont.)·2026

A Markov model cost threshold analysis of potential hepatitis B virus cure regimens.

Clinical and translational gastroenterology·2026

Efficacy and safety of radiofrequency hyperthermia combined with immune checkpoint inhibitors and chemotherapy as first-line treatment for HER2-negative advanced gastric/gastroesophageal junction adenocarcinoma: A propensity score-matched study.

Human vaccines & immunotherapeutics·2026

Pembrolizumab and Peptide Receptor Radionuclide Therapy for Patients with Metastatic Well-Differentiated Neuroendocrine Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Clinical outcomes and blood-based biomarkers across two SABR-treated metastatic settings: oligoprogression under immune checkpoint inhibition and oligometastatic disease.

Oncoimmunology·2026

Is there a role for palliative care in CAR T-cell therapy?

Current opinion in supportive and palliative care·2026

Synergistic Antitumor Effects and Reduced Systemic Toxicity of Berberine Chloride Combined With Cisplatin in a Female BALB/c Mouse Xenograft Model.

Cell biology international·2026

Related Experiment Videos

Reply to Trudeau, M.; Fraser, B. The CADTH pCODR Expert Review Committee Process Explained. Comment on "Rayson et al.

Related Concept Videos

Recurrent Pubic Osteomyelitis and Urosymphyseal Fistula in a Prostate Cancer Survivor: A Multidisciplinary Management Challenge.

Primary Nodal Poroid Hidradenocarcinoma With YAP1::NUTM1 Fusion: Report of a Rare Case.

Association of cancer antigen 15-3 with distant recurrence in immunohistochemically defined breast cancer subtypes in Canadian Cancer Trials Group MA.32.

Pathological assessment of tumour beds in breast excisions post-neoadjuvant therapy: a retrospective cohort study.

Early tumour size changes from neoadjuvant chemotherapy as a predictor of pathologic response in breast cancer.

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with Triple Negative Breast Cancer in Both the Early and Metastatic Setting 2025.

Correction: Gould et al. Emergency Use of Targeted Osmotic Lysis for the Treatment of a Patient with Aggressive Late-Stage Squamous Cell Carcinoma of the Cervix. Curr. Oncol. 2021, 28, 2115-2122.

Trends in Volume, Timeliness, and Reporting Quality of Oncology Systematic and Scoping Reviews: A 25-Year Analysis.

Sentinel Lymph Node Mapping Without Intraoperative Frozen Section in Preoperative Endometrial Intraepithelial Neoplasia/Atypical Endometrial Hyperplasia: Feasibility, Diagnostic Yield, and the Estimated Consequence of Frozen-Section Triage.

Pre-Spondylectomy Radiofrequency Ablation for Spinal Chordoma: An Illustrative Case and Systematic Review of Clinical Applications and Outcomes.

Prediction of Immune Checkpoint Inhibitor-Induced Liver Injury in Patients with Gastrointestinal Cancer: Machine Learning Modeling for Time-Stratified Risk Assessment.

Multidimensional Recovery Trajectories Throughout Breast Cancer Treatment and Survivorship: A Prospective Longitudinal Study.

A Markov model cost threshold analysis of potential hepatitis B virus cure regimens.

Efficacy and safety of radiofrequency hyperthermia combined with immune checkpoint inhibitors and chemotherapy as first-line treatment for HER2-negative advanced gastric/gastroesophageal junction adenocarcinoma: A propensity score-matched study.

Pembrolizumab and Peptide Receptor Radionuclide Therapy for Patients with Metastatic Well-Differentiated Neuroendocrine Tumors.

Clinical outcomes and blood-based biomarkers across two SABR-treated metastatic settings: oligoprogression under immune checkpoint inhibition and oligometastatic disease.

Is there a role for palliative care in CAR T-cell therapy?

Synergistic Antitumor Effects and Reduced Systemic Toxicity of Berberine Chloride Combined With Cisplatin in a Female BALB/c Mouse Xenograft Model.

Related Experiment Videos

Reply to Trudeau, M.; Fraser, B. The CADTH pCODR Expert Review Committee Process Explained. Comment on "Rayson et al....

Abstract:

Related Concept Videos

Related Articles

Reply to Trudeau, M.; Fraser, B. The CADTH pCODR Expert Review Committee Process Explained. Comment on "Rayson et al.